Avenue Therapeutics(ATXI) - 2024 Q1 - Quarterly Results

Exhibit 99.1 Avenue Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Highlights - Raised a total of $9.4 million in gross proceeds from warrant exercise transactions since January 2024 – Miami, FL – May 15, 2024 – Avenue Therapeutics, Inc. (Nasdaq: ATXI) ("Avenue" or the "Company"), a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of neurologic diseases, today reported financial results and recent corporate highl ...